Compare2 funds · 1 pair
Picked · 2YTD
BBCvsARKGVersus · 5Y · 7.0% held in common5–1measures won
Close to theseFee · YTD
Best of the twoNov 4
  • Lowest cost$ a year on $10kBBC 0.65%
  • Most incometrailing 12-month yieldBBC 1.50%
  • Best 5 yearsper yearBBC +0.6%
  • Smallest drop · 1Yworst fall in the past yearARKG −27.5%
Measures won5–1BBC wins · of 6 · 5Y
$10,000 · 5Y$10,290BBC · ARKG $6,752
Lowest cost0.65%BBC · $65 on $10k
Most income1.50%BBC · $150 on $10k
Smallest drop−27.5%ARKG · worst fall in 1Y
Held in common7.0%BBC and ARKG

BBC vs ARKG

5Y
BBC
ARKG
Virtus Biotech Clinical Trials ETF · $34MARK Genomic Revolution ETF · $2.2B
+37.4%3 years · per year$25,933 · $22,153+30.4%
+0.6%5 years · per year$10,290 · $6,752−7.6%
0.65%Expense ratio$65 · $75 on $10k · lower wins0.75%
1.50%12-mo yield$150 · $0 on $10k0.00%
−30.2%Worst dropSmaller wins−27.5%
37.6%VolatilityLower wins45.8%
5–1BBC wins
$10,000 · 5 yearsOne scale
$10k startBBC $10.3kARKG $6.8kOct 2021Nov 2026
Shared top holdingsBBC · ARKG
1.3%PRME1.7%
1.2%NRIX2.8%
0.9%RXRX2.7%
0.9%GENB1.1%
Held in common7.0%
End-of-day Nov 4, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.50%+1.9%+13.1%+43.3%+37.4%+0.6%−30.2%$34M
2BARKGARK Genomic Revolution ETFReadDesk0.75%0.00%+0.4%+71.5%+62.1%+30.4%−7.6%−27.5%$2.2B
End-of-day Nov 4, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs ARKG

5Y
Virtus Biotech Clinical Trials
$10,290
ARK Genomic Revolution
$6,752
$5k$10kNov 2021Nov 2026$10,290$6,752$5k$10kNov 2021Nov 2026$10,290$6,752
MeasureBBCARKG
Fee0.65%0.75%
Cost on $10k a year$65$75
Yield1.50%0.00%
5 years, per year+0.6%−7.6%
3 years, per year+37.4%+30.4%
Worst drop · 1Y−30.2%−27.5%
Volatility · 1Y37.6%45.8%
5–1measures won
BBC first
7.0%
holdings shared
Nov 4, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+35.3%
VIGVanguard
+16.4%
Jan 1Nov 4+35.3%+16.4%
+35.3%Year to date+16.4%
2.9%Yield1.4%
$123BAssets$109B
2–0SCHD wins
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+8.5%
JEPIJ.P. Morgan
+8.8%
Jan 1Nov 4+8.5%+8.8%
+8.5%Year to date+8.8%
12.2%Yield7.8%
$42.1BAssets$46.1B
1–1level
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+13.4%
SPYSPDR
+13.3%
Jan 1Nov 4+13.4%+13.3%
+13.4%Year to date+13.3%
1.0%Yield1.0%
$182BAssets$805B
1–0SPYM wins
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, ARKG

Today
7.0%most shared, BBC and ARKG
BBCARKG
BBC—7.0%
ARKG7.0%—
End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$85most kept, BBC
BBC$150 − $65 = $85
ARKG$0 − $75 = −$75
KeptFee
End-of-day Nov 4, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com